ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $138,890,000 | -1.5% | 5,404,294 | -0.0% | 0.03% | -3.0% |
| Q2 2021 | $140,944,000 | -68.5% | 5,404,300 | -57.3% | 0.03% | -69.7% |
| Q1 2021 | $447,040,000 | +40.1% | 12,664,013 | +0.2% | 0.11% | +31.3% |
| Q4 2020 | $319,042,000 | -32.9% | 12,640,338 | +0.2% | 0.08% | -42.0% |
| Q3 2020 | $475,824,000 | -7.5% | 12,617,992 | +5.1% | 0.14% | -12.3% |
| Q2 2020 | $514,215,000 | +194.8% | 12,008,769 | +33.8% | 0.16% | +139.7% |
| Q1 2020 | $174,427,000 | +2.6% | 8,972,571 | +37.1% | 0.07% | +33.3% |
| Q4 2019 | $169,979,000 | +18.2% | 6,542,678 | +24.0% | 0.05% | +8.5% |
| Q3 2019 | $143,755,000 | +1.5% | 5,274,450 | +0.0% | 0.05% | +4.4% |
| Q2 2019 | $141,618,000 | +47.9% | 5,274,426 | +57.4% | 0.04% | +50.0% |
| Q1 2019 | $95,730,000 | +52.9% | 3,350,532 | +33.6% | 0.03% | +36.4% |
| Q4 2018 | $62,590,000 | – | 2,507,188 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
| Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
| TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
| Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
| Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
| Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
| HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
| Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
| Navalign, LLC | 64,428 | $961,000 | 0.38% |
| Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |